joshmitteldorf.scienceblog.com/2016/05/09/epigenetics-of-aging-and-prospects-for-rejuvenation/
May 9, 2016
Last week, I attended the tail end of a Keystone conference on Epigenetic Regulation of Aging , followed by a oneday brainstorming session to kick off a project called GILGA-mesh, intended to take this bull by the horns. Though
the subjects of the two days were virtually identical, the approach and attitudes of the scientists in attendance set
very different tones. Both days featured smart, creative and careful scientists, but they saw the same material
through different frameworks. Sometimes philosophy makes a difference.
For readers who know me less well, I should introduce my perspective: I believe that aging is an evolved epigenetic
program. When we are young and growing, particular genes are turned on and off with exquisite timing to determine
the growth and development of bones, muscles, and organs. When we are old, the program continues, more slowly
and more diffusely, but inexorably nonetheless. Genes are turned on that destroy us with inflammation and cell
senescence and auto-immunity and programmed cell death, while the systems that protect us from pathogens and
from free radical damage are gradually shut down. Evolution has left nothing to chance.
[I first wrote an academic paper about this idea in 2013, excited by a paper by Aviv Johnson on methylation, but
unaware that Tom Rando had written on the same lines the previous year. Jeff Bowles had hinted at similar ideas in
a paper more than a decade earlier. Soon the field was broken wide open by the work of a bio-statistician.
Steve Horvath ran a computer analysis on thousands of genes as they are expressed in young and old humans,
and produced an epigenetic clock that could accurately report how old a person using measurementis of
methylation in 353 DNA sites in particular.]
Background
Epigenetics is a new science in the 21st century. All the cells in one body have the same DNA (pretty much), but
differernt genes are expressed (translated into proteins) in different tissues and at different times, and this is what
controls the bodys metabolism. In fact, only 2% of our DNA is genes, and 98% determines how the DNA is folded
and spooled, opened and closed at particular times and places, and this in turn controls gene expression. We are
2% genetic and 98% epigenetic.
There is a language called the genetic code which determines how genes are translated into proteins. It was
decoded by Francis Crick and others in the 1950s. It is as simple as it can be, and is completely understood.
There is another language, the epigenetic code that determines gene expression. It is anything-but-simple, with a
convoluted and self-referential syntax that we are just beginning to understand. The epigenetic code starts with
signals embedded in the DNA that serve as start and stop codons. The stretch in between comprises a piece of a
gene, a kind of Gutenberg movable type that is transcribed from the chromosome and then spliced and combined to
form functional RNAs and proteins. The complicated part of the epigenetic code is implemented as a pattern of
methyl and acetyl groups. These are little chemical decorations that attach to the DNA and to the histones (spools
around which DNA is wound up in the cell nucleus for safe storage). The methyl and acetyl groups are continually
being attached and removed according to instructions that come from within the cell and other instructions that are
passed through the blood. It is the methyl and acetyl groups that determine how the DNA is folded and spooled,
which effectively turns particular genes on and off as needed.
The part of the epigenetic code on which we have the best handle at present is called methylation of CpG islands.
Long stretches of DNA have CGCGCGCG on one strand, complemented by GCGCGCGC on the other. Often
1/4
the Cs in this region get an extra methyl group, turning from cytosine to 5-methylcytosine. Then this stretch
becomes a repressor region, a signal to NOT express the adjacent gene.
DNA methylation can be persistent, turning a gene off for decades at a time. When a cell divides and its DNA is
copied, the methylation pattern can be copied with it. This accounts for some of the persistence of epigenetics, and
the way gene expression can be inherited across generations.
DNA methylation has been appreciated for 30 years, but two recent developments make the subject attractive and
accessible to research. (1) There is now a simple lab/computer technique for reading the methylation pattern from
DNA. It relies on commercially available, automated machinery for PCR to sequence a full genome before and after
chemical modification of the methylated Cs. (2) There is now a simple lab/computer technique for changing the
methylation state of any chosen target site in the DNA. It is based on CRISPR technology that is taking genetics
labs by storm the last two years.
2/4
My proposal
As of now, the GILGA-Mesh project is dominated by numbers geeks (like me) who practice the Google approach to
bioinformatics. Huge databases of gene expression are screened for epigenetic candidates that seem to be wellcorrelated with good outcomes. I think what we need is an infusion of biolochemists who understand something
about the bodys signaling networks, and can orient us toward upstream and downstream molecules. Heres my
proposed program:
1. Repeat Horvaths (human) analysis for mice. In other words, identify several hundred places where
methylation is different in young and old mice.
2. Determine which genes are associated with these regions. (Map needed for this should already be
available.)
3/4
3. Look at the set of genes and identify transcription factors. These are likely to be upstream, in that they
control other genes.
4. Start with old mice. Use CRISPR to change the methylation status in a handful of promoter regions that
control transcription factors, making them match the methylation status of young mice.
5. Measure metabolic functions to see if the old mice are more healthy or less after these procedures. Look
particularly for changes in inflammation, propensity for cancer, and especially life span.
If this experiment goes as I expect, we will be ready for rejuvenation experiments in humans.
4/4